(NASDAQ: NTRA) Natera's forecast annual revenue growth rate of 16.24% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.67%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.54%.
Natera's revenue in 2026 is $2,707,075,000.On average, 27 Wall Street analysts forecast NTRA's revenue for 2026 to be $426,810,887,370, with the lowest NTRA revenue forecast at $395,531,602,480, and the highest NTRA revenue forecast at $449,585,666,230. On average, 27 Wall Street analysts forecast NTRA's revenue for 2027 to be $510,270,361,800, with the lowest NTRA revenue forecast at $452,036,117,120, and the highest NTRA revenue forecast at $573,117,219,920.
In 2028, NTRA is forecast to generate $617,225,335,940 in revenue, with the lowest revenue forecast at $547,747,846,000 and the highest revenue forecast at $732,396,527,770.